4//SEC Filing
Collard Craig A 4
Accession 0000950170-25-013042
CIK 0000818033other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 12:43 PM ET
Size
7.7 KB
Accession
0000950170-25-013042
Insider Transaction Report
Form 4
Collard Craig A
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-01-31+1,113,240→ 1,113,240 totalExercise: $1.70Exp: 2035-01-31→ Common Stock (1,113,240 underlying) - Award
Restricted Stock Units
2025-01-31+556,620→ 556,620 totalExercise: $0.00→ Common Stock (556,620 underlying)
Footnotes (2)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (January 31, 2025).
- [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001363558
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 12:43 PM ET
- Size
- 7.7 KB